{"transactions":[{"id":704637,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29134,"kind":"person","name":"Tarnoff Michael E","position":1,"cik":"0001603289","reported_name":"Tarnoff Michael E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-23T00:06:08.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":11887,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant."}],"balance_after":95265,"source":{"system":"sec-edgar","filing":"0001140361-26-029335","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029335/form4.xml","form_type":"4"}},{"id":749153,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":29134,"kind":"person","name":"Tarnoff Michael E","position":1,"cik":"0001603289","reported_name":"Tarnoff Michael E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-04T23:09:40.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":16133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"On January 5, 2026, the Board of Directors approved a grant of 16,133 options to acquire 16,133 shares of Common Stock to each of its non-executive directors, with a grant date of January 20, 2026 (the \"Grant Date\") and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on the Grant Date of $3.77. This option grant was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026."}],"balance_after":16133,"derivative":{"exercise_price":3.77,"exercise_date":"2027-01-20","expiration_date":"2036-01-20","underlying":"Common Stock","underlying_shares":16133},"source":{"system":"sec-edgar","filing":"0001603289-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1603289/000160328926000002/ownership.xml","form_type":"4"}},{"id":749152,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":29134,"kind":"person","name":"Tarnoff Michael E","position":1,"cik":"0001603289","reported_name":"Tarnoff Michael E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-04T23:09:40.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":19063,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On August 6, 2025, the Board of Directors approved a grant of 19,063 options to acquire 19,063 shares of Common Stock of the Company to Dr. Tarnoff as a new non-executive director, with an effective grant date of August 6, 2025 and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on August 6, 2025 of $5.36. The grant was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These Stock Options vest in three equal annual installments beginning the first anniversary of the grant date."}],"balance_after":19063,"derivative":{"exercise_price":5.36,"expiration_date":"2035-08-06","underlying":"Common Stock","underlying_shares":19063},"source":{"system":"sec-edgar","filing":"0001603289-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1603289/000160328926000002/ownership.xml","form_type":"4"}},{"id":749151,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":29134,"kind":"person","name":"Tarnoff Michael E","position":1,"cik":"0001603289","reported_name":"Tarnoff Michael E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-04T23:09:40.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":22214,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents an award of restricted stock units (the \"RSUs\"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the \"Common Stock\"), that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date of January 20, 2026. This grant of RSUs was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs"}],"balance_after":48464,"source":{"system":"sec-edgar","filing":"0001603289-26-000002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1603289/000160328926000002/ownership.xml","form_type":"4"}},{"id":749150,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":29134,"kind":"person","name":"Tarnoff Michael E","position":1,"cik":"0001603289","reported_name":"Tarnoff Michael E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-04T23:09:40.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":26250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of restricted stock units (the \"RSUs\"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the \"Common Stock\"), that are subject to time-based vesting criteria. These RSUs vest in three equal annual installments on the date 12 months following the grant date of August 6, 2025. This grant of RSUs was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs"}],"balance_after":26250,"source":{"system":"sec-edgar","filing":"0001603289-26-000002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1603289/000160328926000002/ownership.xml","form_type":"4"}},{"id":1084576,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29134,"kind":"person","name":"Tarnoff Michael E","position":1,"cik":"0001603289","reported_name":"Tarnoff Michael E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-18T22:06:14.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":17675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 17,675 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") represents 17,675 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant."}],"balance_after":83378,"source":{"system":"sec-edgar","filing":"0001140361-25-026457","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125026457/form4.xml","form_type":"4"}},{"id":1451108,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29134,"kind":"person","name":"Tarnoff Michael E","position":1,"cik":"0001603289","reported_name":"Tarnoff Michael E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-07-19T21:18:32.000Z","date":"2024-07-17","kind":"grant","planned":false,"acquired":true,"shares":20541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 20,541 shares of common stock of AngioDynamics, Inc.(\"AngioDynamics\") represents 20,541 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant."}],"balance_after":65703,"source":{"system":"sec-edgar","filing":"0001140361-24-033636","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036124033636/form4.xml","form_type":"4"}},{"id":1824705,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29134,"kind":"person","name":"Tarnoff Michael E","position":1,"cik":"0001603289","reported_name":"Tarnoff Michael E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-07-22T01:11:03.000Z","date":"2023-07-19","kind":"grant","planned":false,"acquired":true,"shares":17041,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 17,041 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") represents 17,041 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant."}],"balance_after":45162,"source":{"system":"sec-edgar","filing":"0001140361-23-035720","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123035720/form4.xml","form_type":"4"}},{"id":2203169,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29134,"kind":"person","name":"Tarnoff Michael E","position":1,"cik":"0001603289","reported_name":"Tarnoff Michael E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-22T22:20:58.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":7060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 7,060 shares of common stock (\"Common Stock\") of AngioDynamics, Inc., represents 7,060 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/20/2023."}],"balance_after":28121,"source":{"system":"sec-edgar","filing":"0001567619-22-014363","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761922014363/doc1.xml","form_type":"4"}},{"id":2625751,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29134,"kind":"person","name":"Tarnoff Michael E","position":1,"cik":"0001603289","reported_name":"Tarnoff Michael E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-23T22:40:24.000Z","date":"2021-07-21","kind":"grant","acquired":true,"shares":5738,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 5,738 shares of common stock (\"Common Stock\") of AngioDynamics, Inc., represents 5,738 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/21/2022."}],"balance_after":21061,"source":{"system":"sec-edgar","filing":"0001567619-21-013915","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921013915/doc1.xml","form_type":"4"}},{"id":3029859,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29134,"kind":"person","name":"Tarnoff Michael E","position":1,"cik":"0001603289","reported_name":"Tarnoff Michael E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-16T20:17:13.000Z","date":"2020-07-14","kind":"grant","acquired":true,"shares":15323,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 15,323 shares of common stock (\"Common Stock\") of AngioDynamics, Inc., represents 15,323 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/14/2021."}],"balance_after":15323,"source":{"system":"sec-edgar","filing":"0001567619-20-016796","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761920016796/doc1.xml","form_type":"4"}}]}